Elpiscience

Choose Language : EN

EN CN

EN | CN

Harnessing IMMUNOLOGY to Fight Cancer

OUR COMPANY

... capitalizes on the latest biology break-throughs to innovate and develop the next generation of cancer immunotherapies ...

Non-confidential Corporate Overview (Feb. 2021)

1 / 24

view more

NEWS RELEASE

Elpiscience and TRIGR Announce an Exclusive License Agreement of TR009 in Greater China
2021-01-20
SHANGHAI, China and IRVINE, CA, January 20, 2021. Elpiscience Biopharma, a leading China based clinical stage company focused on developing next generation of cancer immunotherapie...
Elpiscience to Present at 39th Annual J.P. MORGAN Healthcare Conference
2021-01-11
Shanghai, China, January 11, 2021. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies,...

view more

Our Science

1 / 24